Molecular defects found in some patients considered to have CVID
Defect type . | Result . |
---|---|
Underlying B-cell defects | |
Defective B-cell cytoplasmic second messengers (Btk)121 | X-linked agammaglobulinemia |
Deletions in immunoglobulin genes122 | |
Underlying T-cell defects | |
Defective T-cell surface receptors (CD40L)123 | CD40L deficiency |
Defective T-cell cytoplastic second messengers (lck, SAP)124 125 | X-linked lymphoproliferative disease, SCID (forme fruste) |
Defective cell cycling, DNA repair enzymes126 | Ataxia-telangiectasia, Nijmegen breakage syndrome |
Defective purine salvage pathway metabolism127 | ADA, PNP deficiency |
Defect type . | Result . |
---|---|
Underlying B-cell defects | |
Defective B-cell cytoplasmic second messengers (Btk)121 | X-linked agammaglobulinemia |
Deletions in immunoglobulin genes122 | |
Underlying T-cell defects | |
Defective T-cell surface receptors (CD40L)123 | CD40L deficiency |
Defective T-cell cytoplastic second messengers (lck, SAP)124 125 | X-linked lymphoproliferative disease, SCID (forme fruste) |
Defective cell cycling, DNA repair enzymes126 | Ataxia-telangiectasia, Nijmegen breakage syndrome |
Defective purine salvage pathway metabolism127 | ADA, PNP deficiency |
SCID indicates severe combined immunodeficiency; ADA, adenosine deaminase; and PNP, purine nucleoside phosphorylase. For explanation of other abbreviations, see Tables 1 and 3.